We retrospectively analysed the course of 42 out of 45 patients suffering from different chondrosarcomas which were treated surgically. We found a prospective 5-and 10-year survival of 64% for both time intervals. Follow-up examination was possible in 21 of 45 patients. Most of them were staged as NED, one as AWD, and 8 of 45 were lost to follow-up. From 16 dead patients 12 died of the disease and 4 of unknown but not to tumor related reasons. Survival was depending significantly on the histopathological grade, and the stage according to Enneking's surgical staging system. Eleven out of forty-five patients developed metastases within a mean period of twelve months after surgery. The survival of these patients was significantly reduced. Patients with centrally located tumors exhibited a distinct but non-significant worse survival than those suffering from peripheral tumors.
Introduction
Chondrosarcoma (CS) is one of the most common malignant tumors of bone. Predominantly, the tumor arises in the middle-aged population and has a predilection for the pelvis and the proximal femur [1] [2] [3] [4] [5] [6] . Furthermore, CS can develop secondary in patients with enchondromatosis or with single or multiple cartilaginous osteochondromas [7] . The clinical occurence of CS is variing extremely. Low-grade CS often grow slowly without or with only a very small rate of distant metastases [8, 9] . In contrast, high-grade, dedifferentiated, or mesenchymal CS are one of the highest malignant tumors of bone with a rather bad prognosis [10, 11] . Surgery is the most important therapeutical modality because chemoand radiotherapy are mostly ineffective [5, 7, 12, 13] .
The purpose of this paper was to evaluate the oncological and functional outcome after surgical treatment of patient suffering from different types of CS.
Patients and methods
Between 1970 and 1995, 45 patients with histologically confirmed CS of bone were treated in our department. In almost (43 of 45) all cases a surgical treatment was performed. For staging the surgical staging system (SSS) of the Musculoskeletal Tumor Society (MSTS) [14] was used. According to the spreading and location of the tumor surgical treatment was performed either with resection or amputation alone, or resection followed by implantation of an endoprosthesis. The intraoperative line of resection was defined according to Enneking's definition [14] as either intralesional. marginal, wide, or radical. Histopathologically. the tumors were graded according to the previously reported grading [15] . Retrospectively, the course of all patients was analysed regarding the development of recurrency, metaslases and the functional outcome. All patients staged alive were clinically reexamined. For follow-up examination, the most recent functional evaluation score of the MSTS [16] was used. For statistical analyses the Kaplan-Meier method for evalution of the cumulative survival and the log-rank test were used.
Results
Forty-two out of these forty-five (24 male, 21 female) patients were treated surgically, three were not referred to an operation either because of refusal or impossibility of resection. The predominant first symptom was pain in the affected anatomical region (29 of 45), 7 of 45 patients observed a painless swelling, in 3 of 45 the tumor was found incidentally, and in 6 of 45 the first symptom was unkown. The average duration of symptoms was 16.1 (0-96) months, the average age at the date of diagnosis 50.2 years.
In 31 of 45 an incisional biopsy was taken prior to the surgical therapy at our department. No complications due to this surgical procedure were observed and in none of the cases the final diagnosis (e.g., stage of the tumor) has changed compared to the grading in the biopsy material. In the remaining 14 patients the diagnosis was made before admission for definitive surgery. The anatomical site is listed in Table 1 . Regarding the grading most of the tumors were CS grade 2. The complete distribution according to grading is shown in Table 2 . According to Enneking's staging system [14] most of the tumors were staged as lib tumors (Table 3) . In seven patients, the tumor developed secondary on the base of preexisting benign lesions such as Ollier's disease or enchondroma.
Surgical treatment
In most of these 42 patients surgical treatment included resection and implantation of an en-doprosthesis. The surgically achieved margins are shown in Table 4 and the complete surgical treatment in Table 5 . Overall, the margin of resection was radical and wide in 15 and marginal or even intralesional in 27 patients (Table 4) . (Figure 1 ). Survival was significantly (P < 0.0001) depending on the histo-pathological grade ( Figure 2 ) and the SSS-stage (P < 0.0005) (Figure 3 ). Although the survival curves exhibit a distinct difference of survival depending on margins of resection no significance could be found (P > 0.05) (Figure 4 ).
Oncological results

Follow
Regarding the anatomical site patients suffering from a peripherally located tumor (femur, humerus, tibia, etc.) exhibited a distinct better but non-significant rate of survival than those tumors with a centrally located tumor (pelvis, vertebrae; P > 0.05; not shown in a graph).
Comparison between primary and secondary CS showed a distinct better but not significant (P > 0.05) survival for pat. with secondary CS.
Metastases
Eleven out of forty-two patients (24%) developed metastases. In 8 of them the metastasis grew within a mean period of 12 months after the first treatment. In three cases the metastasis was already apparent at the date of diagnosis (Table 3 ). Eight of the eleven patients died of the metastasis (73%). One patient was alive with metastatic disease (AWD), one was without disease (NED) and one LTFU.
The main location was the lung (9 of 11), in six patients multiple metastases were evident. Other sites for metastasis were the humerus, femur, sternum, brain, liver, pleura, heart, and ureter. Histological examination exhibited one grade 1, three grade 2 and two grade 3 CS. The original tumor was graded as dedifferentiated CS in three and mesenchymal CS in two cases. The primary anatomical site was the femur (3 x), pelvis (5 x) and one each in the proximal humerus, calcaneus and clavicle.
The mean time of survival in patients with metastasis (8 months) was significantly (P < 0.0001) reduced, the five-year survival rate was 18%. In comparison, the five- year survival rate of patients without metastasis was 64% ( Figure 5 ).
Recurrence
In eight patients (18%) recurrence of the tumor occurred. In four of them more than one recurrence was observed. In 1 patient 9 recurrences were detected over a period of 17 years after a pelvic CS treated with resection and pelvic replacement. After multiple surgical interventions at follow-up four of eight patients were classified as NED, the remaining four were DOD (2 x), DOU (1 x), and LTFU (1 x). Additional metastases occurred in two cases: one each is NED and DOD. The mean period between primary surgery and relapse was 24 months (5-85). Histologically, the tumors were staged as grade 1 CS (3 x), grade 2 (3 x), grade 3 (1 x) and mesenchymal CS (1 x). Secondary CS were the cause of disease in three and primary CS in five cases. In none of the patients the grade of the tumor had changed. The primary tumor was located in the pelvis in three, in the femur in two, and in the humerus, calcaneus and lumbar spine one each. Statitistical analysis of the five-year survival rate did not show any significant differ- ence for patients with (50%) or without (52%) recurrence ( Figure 6 ). Figure 6 Survival depending on the occurrence of recurrences time was 72 months (12-171 months). The mean score was 64% (23%-100%). Eight patients exhibited a score higher than 80% and only in five patients the score was below 40%. Using Enneking's classification [16] in 38% an excellent and in 14% a good result was obtained. In 24% a fair and in 24% a poor result was noted ( Figure 7) . Best results were seen in those patients in whom the tumor could be resected without amputation or endoprosthetic replacement (score 75%). Patients treated with amputation or endoprosthesis exhibited a mean score of 51% and 52%, respectively. Females demonstrated a distinct better score (73%) compared to males (59%). Similar differences were seen for those patients with a central CS (55%) and those tumors located at the limbs (72%). Regarding age, grade, and line of resection no tendency for any dependence of the outcome was detected. Only regarding the surgical stage patients with a stage III disease exhibited the worst score (37%). Statistical analysis of the significance was not possible due to the small number of patients in each group.
Functional follow-up results
Discussion
Different from osteo-and Ewing's sarcomas in most of the chondrosarcomas adjuvant chemo-or radiotherapy is hitherto not helpfull [5, 7, 12, 13] . Reflecting this, in most of the cases surgery is the only therapeutical option. Different to the sarcomas mentioned above patients suffering from CS are older and exhibit a higher frequency of central locations such as the pelvis, proximal humerus and femur. Furthermore, CS can develop more often secondary on the base of primary benign enchondromas or cartilaginous exostoses [7] than osteosarcomas do.
Although the importance of the surgical treatment is well known since decades [1, [17] [18] [19] , there is a relatively small number of reports on long-term results of this group of tumors after standardized diagnostic procedures and treatment [2, 3, 5, 6 ].
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Besides a few clinico-pathological reports, to our knowledge, there is only one other study also including an analysis of the postoperative functional outcome [20] .
In principle, it is difficult to analyse a small number of patients statistically if the character of the tumor is as different as it is in CS and the time of observation includes such a long period of 25 years. In this period the diagnostic tools have been improved dramatically due to the introduction of computered tomography and more recently of the magnetic resonance imaging technique [2, 23] .
Regarding the epidemiological data our results resemble those which are reported previously [1-7, 13, 17] .
In all of the reports the rate of recurrence is rather high: Sanerkin et al. [6] found an overall rate of 58% with 50% for low-grade and 78% for medium-grade CS. Their recurrence rate was depending on the adequacy of resection: in cases with inadequate margins they found a rate of 90% for medium grade CS and of 85% for lowgrade CS. In contrast, after adequate removal the overall rate was 15% with 50% in medium-grade and 6% in lowgrade tumors. All of the recurrences occurred in the first five years. Uncontrolled recurrence, e.g., not amenable for further surgical treatment, was seen in 29% (17% in low-grade and 42% in medium-grade CS). Most often these recurrences were detected in the thoracic region and in the pelvis. Evans et al. [2] also reported that most of the recurrencies occured in the first six to nine years but without a significant difference on the histological grade (grade 1: 40%; grade 2: 60%; grade 3: 47%). Patients who developed metastasis exhibited a non-significant but distinct trend to develop a higher rate of recurrence within a shorter postoperative period than those without any metastasis. In grade 1 and 2 CS the rate of recurrence was also significantly different depending on the achieved surgical margins: those with a local excision or currettage in 92% exhibited a newly growing tumor. In contrast, after wide resection in only 16% a similar problem was evident. Uncontrolled recurrence was noted in 27% of grade 1, 35% of grade 2, and in 35% of grade 3 lesions. The time to recurrence was found to be independent from the stage of the tumor. Comparison between inadequately and adequately resected tumors resulted in a minor difference (P = 0.48) in the 5-year survival rate (88% vs. 91%) and in the 10-year survival rate (79% vs. 84%). Uncontrolled recurrence occurred in 46% after local excision but only in 9.5% after wide resection. In all of the patient with a local excision a recurrence was seen after six years but without any increase in the grade of the CS. Gitelis et al. [3] found a rate of 34% within a mean period of 26.8 months: after an adequate resection (wide or radical) the rate was only 6% but after inadequate surgery (marginal or intralesional resection) 69%. Adequate resection was achieved more often in peripheral tumor than in those located at the axial skeleton, pelvis or proximal limbs. Depending on the grade Gitelis et al. [3] found for grade 1 lesions 33%, grade 2 lesions 38% and grade 3 lesions 19% of recurrence within a mean of 29.6 months. Comparing peripheral with central CS they saw no significant difference (38% vs. 32%) and summarized that adequacy has a greater influence on the incidence of local recurrence than the histological grade does it have. The same independency to the anatomical side was found in our series. Furthermore, they found a disease-free survival in 76% after adequate resection vs. 6% after inadequate resection.
The largest overall number of patients were recently analysed by Lee et al. [5] . They found a frequency of recurrence of 24% with also a significant difference depending on the grade (low-grade 15%; high-grade 30%). In contrast to other authors, they stated that in low-grade CS the rate of recurrence was independent from the surgically achieved margins. But, in high-grade CS the rate was significantly lower after adequate resection. Most of the recurrencies were located at the pelvis.
Analysing the influence of intralesional surgery on the outcome Ozaki et al. [21] summarized that intralesional resection often led to local relapse but it does not always result in metastasis and followed by death. But they mentioned that intralesional resection makes limb salvage more difficult. Bauer et al. [8] compared low-grade CS with enchondroma and saw no significant difference in relapse after 10 years. For enchondromas the rate was 0.04 and for low-grade CS 0.09. Sheth et al. [22] , analysing prognostic factors for chondrosarcomas of the pelvis found that after a multivariate analysis only the tumor grade was influencing the distant relapse. Worst rates for local recurrence (over 50%) were mentioned for dedifferentiated CS by Mercuri et al. [10] and Mitchell etal. [11] .
In comparison to these rates of recurrences our rate of 18% was relatively low. But, in contrast also our fiveyear survival rate was relatively low, although we had a high rate of inadequate resections.
Besides recurrence, development of metastasis is the other major concern: Evans et al. [2] saw in 21% metastases with a significantly increasing rate depending on the stage of the tumor (I: 0%; II: 10%, III: 71%). Most of the metastasis were found in the lung. Gitelis et al. [3] reported a rate of 28% within 27.8 months (2-264) with the same highly significant increase depending on the grade (grade 1: 9%, grade 2: 33%; grade 3: 44%). Furthermore, they saw significantly more metastasis after inadequate resection (42%) than after adequate surgery (14%) and especially when the tumor was located in the central skeleton and not in the periphery. In their analysis Lee et al. [5] found an overall rate of 22% with a rate of 33% in high-grade lesions but only 3% in lowgrade CS (P < 0.0001). Those with exostotic lesions had lower rates than those basing on enchondromas. Similar results have been found by Sanerkin et al. [6] . Our rate of metastasis (24%) was in a comparative range and a significant influence on survival has been seen.
Besides metastasis and relapse the most important aspect in oncological outcome is survival. Gitelis et al. [3] found a 5-year survival rate of 67% and a 10-year survival of 50%. Patients with peripheral tumors showed better results (5-year survival: 89% vs. 49%; 10-year survival: 77% vs. 32%) than those with a central tumor location. Furthermore, survival was depending on the grade: grade 1: 5-year survival 94%, 10-year survival 87%; grade 2: 5-year survival 60%, 10-year survival 41%; grade 3: 5-year survival 44%, 10-year survival 27%. Adequacy of resection also significantly influenced the survival statistics (5-year survival: 82% in adequate vs. 53% in inadequate resection. Because the tumor site has a lower rate of adequate resection this plays a major role in determining the survival. Evans et al. [2] reported similar rates for the overall survival (5-year surival 77%, 10-year survival 67%) but demonstrated a highly significant better outcome for grade 1 and 2 than for grade 3 tumors. Also Lee et al. [5] found a better survival rate for low-grade CS adequately resected than for high-grade and inadequately resected tumors.
Compared to other studies our data showed a slightly lower 5-year survival rate of 64% when compared to the literature (Evans et al. [2] : 77%/67%; Gitelis et al. [3] : 67%/50%; Sanerkin et al. [6] : 78%/58%). But, in our analysis the rate of survival did not change within the following period from 5-10 years after surgery. Regarding the 10-year survival rate ours was slightly higher than previously reported survival rates of other studies (Evans et al. [2] : 67%; Gitelis et al. [3] : 50%; Sanerkin et al. [6] 58%). The reason therefore is unknown. Probably, due to the small number of patients we lost more patients in the first than in the second five-year period.
Functional outcome
Musculoskeletal function is one of the factors that can be influenced relatively well by the surgeon and the patient itself. It is one of the criteria for the remaining quality of life in surviving patients. Thus, this is a major aim in the treatment of oncological patients. To our knowledge, this is the second report about a standardised analysis concerning the functional postoperative outcome in pat. suffering from CS. Only van Loon et al. [20] reported in 1994 about the data obtained from 16 patients. After a mean follow-up of 104 months they found a mean score of 77% (range 30%-100%). Depending on the location of the tumor better results were seen in patients with CS at the lower limb (n = 11: 77%) than at the upper limb (n -57: 1%). In our analysis the mean score was slightly worse (68%), but the range was comparable (23%-100%). Independent from this we saw excellent or good results in 52%.
Although the studies mentioned above and our own investigation are retrospective analyses with different study designs what makes comparison difficult or even imposible, one can summarize that adequacy of resection has to be one of the most important surgical aims. Regarding the rate of recurrence reported by several authors, adequate resection with wide margins is of importance even in low-grade CS. Adequacy of resection also has an important influence on the development of metastases and thus on the most important pointsurvival. Consequently, because of the fact that development of metastases and recurrencies seem to influence each other we also recommend wide resection even in low-grade CS like it is recommended by other authors [7, 12, 13] . Theoretically, improvement of the oncological results seems to be difficult because of the rather high rate of centrally located CS which are related with worse results compared to the peripherally located tumors. But, meanwhile a distinct improvement in the diagnosis and thus in the determination of the correct tumor extension is feasible [2, 23] . Consequently, planning of the surgical intervention has also been improved, particularly for central locations. Thus, improvement of the rate of survival without compromising oncological results should be possible. In addition, also functional results should be improvable because of the learning curve in operative procedures such as pelvic replacement and/or technical improvements such as tumor endoprostheses [24, 25] . Further studies should be undertaken prospectively [5, 26] in order to evaluate whether there may be an additional adjuvant chemo-or radiotherapy treatment with recently described techniques such as hyperbaric oxigenation and/or hyperthermie.
